Division of Clinical Pharmacology, Free Radicals in Medicine Core, Vanderbilt University Medical Center, Nashville, Tennessee; and.
Am J Physiol Heart Circ Physiol. 2013 Nov 15;305(10):H1417-27. doi: 10.1152/ajpheart.00089.2013. Epub 2013 Sep 16.
Based on mosaic theory, hypertension is a multifactorial disorder that develops because of genetic, environmental, anatomical, adaptive neural, endocrine, humoral, and hemodynamic factors. It has been recently proposed that oxidative stress may contribute to all of these factors and production of reactive oxygen species (ROS) play an important role in the development of hypertension. Previous studies focusing on the role of vascular NADPH oxidases provided strong support of this concept. Although mitochondria represent one of the most significant sources of cellular ROS generation, the regulation of mitochondrial ROS generation in the cardiovascular system and its pathophysiological role in hypertension are much less understood. In this review, the role of mitochondrial oxidative stress in the pathophysiology of hypertension and cross talk between angiotensin II signaling, pathways involved in mechanotransduction, NADPH oxidases, and mitochondria-derived ROS are considered. The possible benefits of therapeutic strategies that have the potential to attenuate mitochondrial oxidative stress for the prevention/treatment of hypertension are also discussed.
基于镶嵌理论,高血压是一种多因素疾病,由遗传、环境、解剖、适应性神经、内分泌、体液和血液动力学等因素共同作用而产生。最近有人提出,氧化应激可能与所有这些因素有关,活性氧(ROS)的产生在高血压的发生发展中起重要作用。以前的研究集中于血管 NADPH 氧化酶的作用,为这一概念提供了有力的支持。虽然线粒体是细胞内 ROS 产生的最重要来源之一,但线粒体 ROS 产生在心血管系统中的调节及其在高血压中的病理生理作用还知之甚少。在这篇综述中,我们探讨了线粒体氧化应激在高血压病理生理学中的作用,以及血管紧张素 II 信号转导、机械转导途径、NADPH 氧化酶和线粒体来源的 ROS 之间的相互作用。还讨论了具有减轻线粒体氧化应激潜力的治疗策略在高血压的预防/治疗方面可能带来的益处。